MedVellum
MedVellum
Back to Library
Ophthalmology
Rheumatology
Internal Medicine
EMERGENCY

Anterior Uveitis

High EvidenceUpdated: 2025-12-23

On This Page

Red Flags

  • Hypopyon (pus in anterior chamber) — severe inflammation, consider infection
  • Significant visual loss — urgent ophthalmology
  • Irregular pupil from synechiae — risk of complications
  • Posterior segment involvement — intermediate/posterior uveitis
  • Bilateral simultaneous onset — consider systemic disease
Overview

Anterior Uveitis

1. Clinical Overview

Summary

Anterior uveitis (iritis/iridocyclitis) is inflammation of the iris and ciliary body, presenting as a painful red eye with photophobia, lacrimation, and blurred vision. It is the most common form of uveitis, accounting for 50-90% of cases. The condition is strongly associated with HLA-B27 and seronegative spondyloarthropathies (ankylosing spondylitis, reactive arthritis, psoriatic arthritis, IBD-associated arthritis). While idiopathic in ~50% of cases, systemic diseases such as sarcoidosis, Behçet's, herpes infections, and tuberculosis must be considered. Treatment requires urgent ophthalmology referral, topical corticosteroids to reduce inflammation, and cycloplegic agents to relieve pain and prevent synechiae formation.

Key Facts

  • Definition: Inflammation of the iris (iritis) ± ciliary body (iridocyclitis)
  • Prevalence: Most common form of uveitis; 17-52 per 100,000
  • Presentation: Painful red eye, photophobia, blurred vision, lacrimation
  • Classic Sign: Ciliary flush (circumcorneal limbal injection)
  • Slit Lamp: Cells and flare in anterior chamber
  • Key Association: HLA-B27 (50% of anterior uveitis; 90% of AS-related uveitis)
  • Key Management: Urgent ophthalmology; topical steroids + cycloplegics

Clinical Pearls

"Painful Red Eye with Photophobia = Think Uveitis": Unlike conjunctivitis (gritty, no photophobia, no visual loss) or episcleritis (localised, minimal pain), anterior uveitis causes deep aching pain, consensual photophobia, and vision changes.

Consensual Photophobia: Shining light in the UNAFFECTED eye causes pain in the AFFECTED eye. This is diagnostic of anterior uveitis — ciliary spasm is triggered bilaterally.

HLA-B27 Link: Up to 50% of anterior uveitis is HLA-B27 positive. Ask about back pain, stiffness, joint symptoms.

Why This Matters Clinically

Anterior uveitis requires prompt recognition and treatment to prevent complications such as posterior synechiae (iris adhesion to lens), glaucoma, cataract, and permanent visual loss. Recurrent episodes are common. Many cases indicate underlying systemic disease, making appropriate investigation important.


2. Epidemiology

Incidence & Prevalence

  • Incidence: 17-52 per 100,000 per year
  • Prevalence: 38-114 per 100,000
  • Proportion of uveitis: 50-90% of all uveitis cases
  • Trend: Stable; increasing recognition

Demographics

FactorDetails
AgePeak 20-50 years; can occur at any age
SexSlight male predominance in HLA-B27 positive cases; otherwise equal
EthnicityParallels HLA-B27 prevalence; higher in Caucasians, Native Americans
GeographyHigher in northern Europe (HLA-B27 frequency)

Risk Factors

FactorDetails
HLA-B27Present in ~50% of anterior uveitis; stronger predictor of recurrence
Seronegative spondyloarthropathyAnkylosing spondylitis (AS), psoriatic arthritis, reactive arthritis, IBD-associated
Previous episodeRecurrence common (40-50%)
Systemic inflammatory diseaseSarcoidosis, Behçet's disease
InfectionHerpes simplex/zoster, tuberculosis, syphilis, Lyme disease
SmokingMay increase risk of recurrence

Aetiology Classification

CategoryExamplesFrequency
IdiopathicNo identifiable cause~50%
HLA-B27 associatedAS, reactive arthritis, psoriatic arthritis, IBD-arthritis20-30%
InfectiousHerpes simplex, herpes zoster, TB, syphilis, Lyme, toxoplasmosis5-10%
Systemic inflammatorySarcoidosis, Behçet's, JIA, TINU syndrome5-15%
Masquerade syndromesLymphoma, leukaemia, retinoblastoma (pseudo-uveitis)Rare

3. Pathophysiology

Mechanism

Step 1: Immune Activation

  • Breakdown of ocular immune privilege
  • T-cell mediated inflammation (usually CD4+ Th1 or Th17)
  • Antigen presentation by iris/ciliary body macrophages
  • Cytokine release (IL-1, IL-6, TNF-alpha, IFN-gamma)

Step 2: Blood-Aqueous Barrier Breakdown

  • Increased vascular permeability
  • Protein leakage into anterior chamber (flare)
  • Inflammatory cell infiltration (cells)
  • Fibrin deposition (if severe)

Step 3: Clinical Manifestations

  • Ciliary muscle spasm → photophobia, pain
  • Inflammatory cells/protein in anterior chamber → vision blur
  • Pupil constriction (miosis)
  • Iris vascular engorgement

Step 4: Complications

  • Posterior synechiae (iris adhesion to lens) → irregular pupil
  • Seclusio pupillae (360° synechiae) → pupil block glaucoma
  • Trabecular meshwork obstruction → secondary open-angle glaucoma
  • Chronic inflammation → cataract
  • Band keratopathy (calcium deposition in cornea)

HLA-B27 Mechanism

  • Molecular mimicry with bacterial antigens
  • Arthritogenic peptide presentation
  • Microbiome dysbiosis
  • Cross-reactive T-cell response between gut/joint/eye

4. Clinical Presentation

Symptoms

Classic Triad:

Additional Symptoms:

Signs

SignDescription
Ciliary flush (limbal injection)Circumcorneal ring of redness around the cornea; deeper than conjunctivitis
Cells in anterior chamberWBCs seen floating in aqueous on slit lamp (graded 0-4+)
FlareProtein in aqueous causing "beam" visible on slit lamp (Tyndall effect)
MiosisSmall pupil (due to sphincter spasm)
Posterior synechiaeIris adhesion to lens; irregular pupil
HypopyonWhite layering of pus in lower anterior chamber (severe inflammation)
Keratic precipitates (KPs)Inflammatory deposits on posterior cornea

Red Flags

[!CAUTION] Red Flags — Urgent investigation/management required:

  • Hypopyon — Consider endophthalmitis (infectious), Behçet's, HLA-B27 severe flare
  • Significant visual loss — Posterior segment involvement, macular oedema
  • Elevated IOP — Secondary glaucoma
  • Bilateral simultaneous onset — Strongly suggests systemic disease
  • Chronic/recurrent despite treatment — Investigate for underlying cause
  • Posterior segment signs — Vitritis, chorioretinitis (not just anterior)

Pain
Deep, dull aching (worsens with accommodation)
Photophobia
Often consensual (light in other eye causes pain)
Redness
Red eye, especially around the limbus
5. Clinical Examination

Structured Approach

General Inspection:

  • Red eye with circumcorneal (limbal) injection
  • Photophobia on examination
  • May be tearing

Visual Acuity:

  • Document before and after dilation
  • May be reduced (usually mild unless complications)

Pupil Examination:

  • Miosis (small, reactive)
  • Irregular if posterior synechiae present
  • Test consensual photophobia (light in unaffected eye → pain in affected eye)

Slit Lamp Examination (Key):

FindingGradeSignificance
Cells (WBCs in AC)0 to 4+Activity marker
Flare (protein in AC)0 to 4+BAB breakdown; chronicity
Keratic precipitatesFine/granulomatousFine = non-granulomatous; "mutton-fat" = granulomatous (sarcoid, TB)
HypopyonPresent/absentSevere inflammation
Posterior synechiaePresent/absentComplication; dilate to break
Iris nodulesKoeppe/BusaccaGranulomatous; consider sarcoid

Intraocular Pressure (IOP):

  • May be low (ciliary shutdown) or high (trabecular obstruction)

Fundoscopy:

  • Rule out posterior segment involvement
  • Vitritis suggests intermediate/posterior uveitis

Special Tests

TestPurpose
Slit lamp biomicroscopyEssential; diagnose and grade inflammation
TonometryMeasure IOP
Dilated fundoscopyRule out posterior involvement
GonioscopyIf angle closure concern

6. Investigations

First-Line (First Episode, Uncomplicated)

May not require extensive workup if:

  • First episode
  • Unilateral
  • Resolves quickly with treatment
  • No systemic symptoms

Investigate if Recurrent, Bilateral, or Atypical

TestPurpose
HLA-B27Strong association; guides follow-up
Chest X-raySarcoidosis, tuberculosis
ACE levelSarcoidosis
Syphilis serology (VDRL/TPHA)Exclude syphilis
FBC, CRP/ESRInflammatory markers
Quantiferon/MantouxTuberculosis
UrinalysisTubulointerstitial nephritis (TINU syndrome)

Specialist Investigation

InvestigationIndication
OCT maculaCystoid macular oedema
Fluorescein angiographyPosterior segment, vasculitis
B-scan ultrasoundIf poor view of fundus
Lumbar punctureCNS involvement suspected (MS, Behçet's)

7. Management

Management Algorithm

Immediate Management

ActionDetails
Urgent ophthalmology referralSame-day/next-day specialist review essential
Topical corticosteroidsPrednisolone acetate 1% hourly initially, then taper
Cycloplegic agentsCyclopentolate 1% TDS or Atropine 1% BD — relieves pain, prevents synechiae

Pharmacological Management

DrugClassDosePurpose
Prednisolone 1%Topical steroidHourly initially → taper over weeksReduce inflammation
Dexamethasone 0.1%Topical steroidAlternative to prednisoloneStronger penetration
Cyclopentolate 1%CycloplegicTDSShort-acting; pain relief
Atropine 1%CycloplegicBDLong-acting; prevent synechiae
Homatropine 2%CycloplegicTDSIntermediate duration

Follow-Up and Monitoring

  • Review in 1-7 days depending on severity
  • Continue steroids until cells clear, then slow taper (risk of rebound)
  • Monitor IOP (steroid response)
  • Taper cycloplegics once inflammation controlled

Management of Complications

ComplicationManagement
Posterior synechiaeIntensive mydriatics to break synechiae; subconjunctival mydriatics if resistant
Secondary glaucomaIOP-lowering drops (avoid prostaglandins in active inflammation)
CataractSurgery when inflammation controlled
CMOIntensive topical steroids, peri-ocular/systemic steroids

Systemic Treatment (Recurrent/Severe)

IndicationOptions
Refractory to topicalPeriocular steroid injection
Frequent recurrenceSystemic methotrexate, mycophenolate, azathioprine
Behçet's, severe HLA-B27Adalimumab (anti-TNF), infliximab
Underlying diseaseTreat AS, sarcoidosis, etc.

8. Complications

Complications of Anterior Uveitis

ComplicationMechanismManagement
Posterior synechiaeIris adherence to lensMydriatics; may need surgical lysis
Seclusio pupillae360° synechiae; iris bombeLaser iridotomy
Secondary glaucomaTrabecular obstruction, pupil blockIOP-lowering treatment
CataractChronic inflammation or steroidsSurgery when quiet
Band keratopathyCalcium deposition (chronic)EDTA chelation
Cystoid macular oedemaChronic BAB breakdownSteroids; anti-VEGF
Phthisis bulbiEnd-stage; ciliary shutdownRare; enucleation if painful

Treatment-Related Complications

TreatmentComplication
Topical steroidsSteroid-induced glaucoma, cataract (prolonged use), rebound inflammation (too rapid taper)
CycloplegicsBlurred vision, photophobia, accommodation loss

9. Prognosis & Outcomes

Natural History

Acute anterior uveitis typically resolves within weeks with appropriate treatment. However, recurrence is common (40-50%), particularly in HLA-B27 positive patients. Chronic or recurrent cases may develop complications leading to permanent visual impairment.

Outcomes

OutcomeRate
Resolution with treatment95%+ for acute episode
Recurrence40-50% overall; higher in HLA-B27+
Vision loss5-10% with complications
Chronic uveitis10-15% develop chronic course

Prognostic Factors

Good Prognosis:

  • First episode
  • Acute presentation
  • Good response to topical steroids
  • No synechiae
  • No underlying chronic disease

Poor Prognosis:

  • Recurrent episodes
  • HLA-B27 positive (more recurrences)
  • Granulomatous uveitis
  • Posterior involvement
  • Systemic disease (Behçet's, JIA)
  • Complications present at diagnosis

10. Evidence & Guidelines

Key Guidelines

  1. NICE CKS: Red Eye (2023) — Primary care guidance on referral and initial management.
  2. American Academy of Ophthalmology Uveitis Preferred Practice Pattern (2019) — Comprehensive specialist guidance.
  3. British Society for Rheumatology HLA-B27 SpA Guidelines — Management of associated spondyloarthropathy.

Key Studies

Adalimumab for Uveitis (VISUAL 1 & 2 Trials, 2016) — Adalimumab effective for non-infectious intermediate, posterior, and panuveitis.

  • PMID: 27457817

Evidence Strength

InterventionLevelKey Evidence
Topical steroids for acute AUExpert consensusStandard of care; no RCTs vs placebo
CycloplegicsExpert consensusReduces pain, prevents synechiae
Adalimumab for recurrent/refractory1bVISUAL trials
HLA-B27 testing in recurrent AUExpert consensusGuides systemic evaluation

11. Patient/Layperson Explanation

What is Anterior Uveitis?

Anterior uveitis is inflammation inside the front part of the eye, affecting the iris (the coloured part) and the ciliary body (which focuses the lens). It causes a painful, red eye with sensitivity to light and blurred vision. It is sometimes called "iritis."

Why does it happen?

  • In about half of cases, no specific cause is found
  • It's often linked to a gene called HLA-B27, which is also associated with types of arthritis affecting the spine
  • Infections (herpes, tuberculosis) and other inflammatory conditions (sarcoidosis, Behçet's) can cause it
  • It can keep coming back, especially if you have HLA-B27

How is it treated?

  1. Eye drops: Steroid drops to reduce inflammation (used frequently at first, then tapered slowly)
  2. Dilating drops: To relieve pain and prevent the iris from sticking to the lens
  3. Follow-up: Regular eye checks until inflammation clears and drops are stopped
  4. Investigation: If it keeps coming back, blood tests and X-rays may be needed to look for underlying causes

What to expect

  • Most episodes clear up within a few weeks with treatment
  • It can come back — 40-50% of people have another episode
  • If you have HLA-B27 or a related condition, recurrences are more likely
  • Stopping drops too quickly can cause the inflammation to return

When to seek help

  • If you have a painful red eye with sensitivity to light — see a doctor the same day
  • If your vision gets worse
  • If you see a white layer at the bottom of your eye (hypopyon)
  • If you have back pain or joint stiffness (may indicate underlying arthritis)

12. References

Primary Guidelines

  1. National Institute for Health and Care Excellence. Red eye. NICE Clinical Knowledge Summaries. 2023. NICE CKS
  2. Jabs DA, et al. Standardization of uveitis nomenclature (SUN). Am J Ophthalmol. 2005;140(3):509-516. PMID: 16196117

Key Trials

  1. Jaffe GJ, et al. Adalimumab in patients with active noninfectious uveitis (VISUAL I). N Engl J Med. 2016;375(10):932-943. PMID: 27602665
  2. Nguyen QD, et al. Adalimumab for prevention of uveitic flare in patients with inactive non-infectious uveitis (VISUAL II). Lancet. 2016;388(10050):1183-1192. PMID: 27457817
  3. Rothova A, et al. Causes and frequency of blindness in patients with intraocular inflammatory disease. Br J Ophthalmol. 1996;80(4):332-336. PMID: 8703883

Further Resources

  • Fight for Sight: www.fightforsight.org.uk
  • Moorfields Eye Hospital: www.moorfields.nhs.uk
  • Uveitis Information Group: www.uveitis.net


Medical Disclaimer: MedVellum content is for educational purposes and clinical reference. Anterior uveitis requires urgent specialist assessment — seek same-day ophthalmology review if suspected. This content does not constitute medical advice for individual patients.

Last updated: 2025-12-23

At a Glance

EvidenceHigh
Last Updated2025-12-23
Emergency Protocol

Red Flags

  • Hypopyon (pus in anterior chamber) — severe inflammation, consider infection
  • Significant visual loss — urgent ophthalmology
  • Irregular pupil from synechiae — risk of complications
  • Posterior segment involvement — intermediate/posterior uveitis
  • Bilateral simultaneous onset — consider systemic disease

Clinical Pearls

  • **Consensual Photophobia**: Shining light in the UNAFFECTED eye causes pain in the AFFECTED eye. This is diagnostic of anterior uveitis — ciliary spasm is triggered bilaterally.
  • **HLA-B27 Link**: Up to 50% of anterior uveitis is HLA-B27 positive. Ask about back pain, stiffness, joint symptoms.
  • **Red Flags** — Urgent investigation/management required:
  • - **Hypopyon** — Consider endophthalmitis (infectious), Behçet's, HLA-B27 severe flare
  • - **Significant visual loss** — Posterior segment involvement, macular oedema

Guidelines

  • NICE Guidelines
  • BTS Guidelines
  • RCUK Guidelines